2mg ghk cu a day How Often to Inject GHK-Cu GHK-CU Peptide Dosage: Complete Guide

10.1016/s1474-4422(08)70117-0 Lancet Neurol

Dalal N

The Phase 2 trial enrolled participants with obesity and evaluated multiple dose levels over 48 weeks: 1 mg dose: 8.7% average body weight reduction 4 mg dose (escalated from 2 mg): 17.1% average body weight reduction 8 mg dose (escalated from 2 mg): 22.8% average body weight reduction 12 mg dose (escalated from 2 mg): 24.2% average body weight reduction Placebo: 2.1% average body weight reduction Those Phase 2 numbers were striking enough

clinical studies have shown that using GHK-Cu can lead to measurable improvements

Some users report temporary increased shedding when starting copper peptide protocols